Biogen, Inc. (BIIB)
181.55
-3.35
(-1.81%)
USD |
NASDAQ |
Mar 13, 16:00
181.25
-0.30
(-0.17%)
Pre-Market: 20:00
Biogen Shareholders Equity (Quarterly) : 18.26B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 8.658B |
| Eli Lilly & Co. | 26.54B |
| Merck & Co., Inc. | 52.61B |
| AbbVie, Inc. | -3.27B |
| Pfizer Inc. | 86.48B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.44B |
| Total Liabilities (Quarterly) | 11.18B |
| Debt to Equity Ratio | 0.3647 |
| Current Ratio | 2.679 |
| Net Debt Paydown Yield | -0.01% |